Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?

Blood

Volumn 112, Issue 10, 2008, Pages 4353-4354

  Giannini, Carlo ^a   Gragnani, Laura ^a   Piluso, Alessia ^a   Caini, Patrizio ^a   Petrarca, Antonio ^a   Monti, Monica ^a   Laffi, Giacomo ^a   Zignego, Anna Linda ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CRYOGLOBULIN; MESSENGER RNA; TNFSF13B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTHRALGIA; B LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENOTYPE; HEPATITIS C VIRUS; HEREDITY; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; LETTER; MONOCYTE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PURPURA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; RISK FACTOR; SJOEGREN SYNDROME; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION INITIATION; VIRUS HEPATITIS; WEAKNESS; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEPATITIS C; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CRYOGLOBULINEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 58149160047     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-170613     Document Type: Letter

References (10)

1. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007;39:2-17.
2. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med. 1974;57:775- 788.
3. Do RK, Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 2002;13:19-25.
4. Fabris M, Quartuccio L, Sacco S, et al. B-Lymphocyte stimulator (BLyS) upregulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford). 2007;46:37-43.
5. Toubi E, Gordon S, Kessel A, et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun. 2006;27:134-139.
6. Sene D, Limal N, Ghillani-Dalbin P, Saadoun D, Piette JC, Cacoub P. Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford). 2007;46:65-69.
7. Novak AJ, Grote DM, Ziesmer SC, et al. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol. 2006;24:983-987.
8. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun. 2002;3: 424-429.
9. De Re V, Caggiari L, Simula MP, et al. Role of the HLA class II: HCV-related disorders. Ann N Y Acad Sci. 2007;1107:308-318.
10. Bianchettin G, Bonaccini C, Oliva R, et al. Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls. J Virol. 2007;81:4564-4571.